References
- Leveno KJ, Little BB, Cunningham FG. The national impact of ritodrine hydrochloride for inhibition of preterm labor. Obstet Gynecol 1990; 76: 12–5.
- Hendricks CH, Cibils LA, Pose SV, Eskes TKA. The pharmacologic control of excessive uterine activity with isoxuprine. Am J Obstet Gynecol 1961; 82: 1064–78.
- Fuchs F, Fuchs AR, Poblete VF Risk A. Effect of alcohol on threatened premature labor. Am J Obstet Gynecol 1967; 99: 627–37.
- Merkatz IR, Peter JB, Barden TP. Ritodrine hydrochloride: a beta-mimetic agent for use in preterm labor. II. Evidence of efficacy. Obstet Gynecol 1980; 56: 1–6.
- Larsen JF, Hansen KM, Hesseldahl H, Kristoffersen K, Larsen PK, Osler M et al. Ritodrine in the treatment of preterm labor. A clinical trial to compare a standard treatment with three regimens involving the use of ritodrine. Br J Obstet Gynaecol 1980; 87: 949–57.
- Ingemarsson I. Effect of terbutaline on premature labor. A double-blind placebo-controlled study. Am J Obstet Gynecol 1975; 125: 520–4.
- King JF Grant A, Keirse MJNC, Chalmers I. Beta-mimetics in preterm labor: an overview of randomized controlled trials. Br J Obstet Gynaecol 1988; 95: 211–22.
- Cotton DB, Strassner HT, Hill LM, Schifrin BS, Paul RH. Comparison of magnesium sulfate, terbutaline and a placebo for inhibition of preterm labor. A randomized study. J Reprod Med 1984; 29: 92–7.
- Dawood MY. Neurohypophyseal hormones. In: Fuchs F, Klopper A (eds): Endocrinology of Pregnancy. 3rd edn. Harper & Row, 1983: 204.
- Fuchs AR, Fuchs F. Endocrinology of human parturition: a review. Br J Obstet Gyanecol 1984; 91: 948–67.
- Fuchs AR, Fuchs F Husslein P Soloff MS, Fernström MJ. Oxytocin receptors and human parturition: a dual role for oxytocin in initiation of labor. Science 1982; 215: 1396–8.
- Bossmar T, Akerlund M, Fantoni G, Szamatowicz J, Melin P, Maggi M. Receptors for and myometrial responses to oxytocin and vasopressin in preterm and term human pregnancy: effects of the oxytocin antagonist atosiban. Am J Obstet Gynecol 1994; 171: 1634–42.
- Maggi M, Del Carlo P, Fantoni G, Giannini S, Torrisi C, Casparis D et al. Human myometrium during pregnancy contains and responds to V1 vasopressin receptors as well as oxytocin receptors. J Clin Endocrinol Metab 1990; 70: 1142–54.
- Kimura T, Takemura M, Nomura S, Nobunaga T, Kubota Y, Inoue T et al. Expression of oxytocin receptor in human pregnant myometrium. Endocrinol 1996; 137: 780–5.
- Price PH. Review of Betamimetic Drugs for Tocolysis. Report to Special FDA Public Meeting on Re-evaluation of Ritodrine Labelling, October 1992.
- Challis JRG, Mitchell MD. Basic mechanisms of preterm labour. Res Clin Forums 1994; 16: 39–52.
- Fuchs AR, Husslein P, Fuchs F. Oxytocin and the initiation of human parturition II. Stimulation of prostaglandin production in human decidua by oxytocin. Am J Obstet Gynecol 1981; 141: 694.
- Husslein P, Fuchs AR, Fuchs F. Oxytocin and the initiation of human parturition. I. Prostaglandin release during induction of labor by oxytocin. Am J Obstet Gynecol 1981; 141: 688–93.
- Husslein P. The importance of oxytocin and prostaglandins to the mechanism of labor in humans. Wien Klin Wochenschr 1984; 155: 1–32.
- Lefebvre DL, Giaid A, Bennett H, Lariviere R, Zingg HH. Oxytocin gene expression in rat uterus. Science 1992; 256: 1553–5.
- Chibbar R, Miller FD, Mitchell BF. Synthesis of oxytocin in amnion, chorion and decidua may influence the timing of human parturition. J Clin Invest 1993; 91: 185–92.
- Du Vigneaud V Ressler C, Trippett S. The sequence of amino acids in oxytocin, with a proposal for the structure of oxytocin. J Biol Chem 1953; 205: 949–57.
- Law HD, Du Vigneaud V. Synthesis of 2-p-methoxyphenylalanine oxytocin (O-Methyl-oxytocin) and some observations on its pharmacological behaviour. J Am Chem Soc 1960; 82: 4579–81.
- Melin P, Vilhardt H, Lindeberg G, Larsson L-E, Akerlund M. Inhibitory effect of O-alkylated analogues of oxytocin and vasopressin on human and rat myometrial activity. J Endocrinol 1981; 88: 173–80.
- Melin P Trojnar J, Johansson B, Vilhardt H, Akerlund M. Synthetic antagonists of the myometrial response to vasopressin and oxytocin. J Endocrinol 1986; 111: 125–31.
- Akerlund M, Carlsson AM, Melin P, Trojnar J. The effect on the human uterus of two newly developed competitive inhibitors of oxytocin and vasopressin. Acta Obstet Gynecol Scand 1985; 64: 499–504.
- Akerlund M, Hauksson A, Lundin S, Melin P, Trojnar J. Vasotocin analogues which competitively inhibit vasopressin stimulated uterine activity in healthy women. Br J Obstet Gynaecol 1986; 93: 22–7.
- Hauksson A, Akerlund M, Melin P Uterine blood flow and myocardial activity at menstruation, and the action of vasopressin and a synthetic antagonist. Br J Obstet Gynaecol 1988; 95: 898–904.
- Akerlund M, Stromberg P, Hauksson A, Andersen LF, Lyndrup J, Trojnar J et al. Inhibition of uterine contractions of premature labour with an oxytocin analogue. Results from a pilot study. Br J Obstet Gynaecol 1987; 94: 1040–4.
- Andersen LF, Lyndrup J, Akerlund M, Melin P. Oxytocin receptor blockade. a new principle in the treatment of preterm labour? Am J Perinatol 1989; 6: 196–9.
- Goodwin TM, Paul R, Silver H, Spellacy W, Parsons M, Chez R et al. The effect of the oxytocin antagonist atosiban on preterm uterine activity in the human. Am J Obstet Gynecol 1994; 170: 474–8.
- Goodwin TM, Valenzuela G, Silver H, Hayashi R, Creasy GW, Lane R. Treatment of preterm labour with the oxytocin antagonist atosiban. Am J Perinatol 1996; 13: 143–6.
- Goodwin TM, Valenzuela GJ, Silver H, Creasy G and the Atosiban Study Group. Dose ranging study of the oxytocin antagonist atosiban in the treatment of preterm labor. Obstet Gynecol 1996; 88: 331–6.
- Romero R, Sibai BM, Sanchez-Ramos L, Valenzuela GJ, Veille J-C, Tabor B et al. An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue. Am J Obstet Gynecol 2000; 182: 1173–83.
- Valenzuela GJ, Sanchez-Ramos L, Romero R, Silver HM, Koltun WD, Millar L et al. Maintenance treatment of preterm labor with the oxytocin antagonist atosiban. Am J Obstet Gynecol 2000; 182: 1184–90.
- The Canadian and Israeli Atosiban Study Group. Doubleblind, randomized, controlled trial of atosiban and ritodrine in the treatment of preterm labor: a multicenter effectiveness and safety study. Am J Obstet Gynecol 2000; 182: 1191–9.
- The European Atosiban Study Group. The oxytocin antagonist atosiban versus the beta-agonist terbutaline in the treatment of preterm labor. A randomized, double-blind, controlled study. Acta Obstet Gynecol Scand 2001; 80: 413–22.
- The French and Australian Atosiban Study Group. Treatment of preterm labor with the oxytocin antagonist atosiban: a double-blind, randomized, controlled comparison with salbutamol. Eur J Obstet Gynecol Reprod Biol 2001; 98: 177–85.
- The Worldwide Atosiban versus Beta-agonists Study Group. Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. Br J Obstet Gynaecol 2001; 108: 13342.
- Helmer H, Brunbauer M, Schaten C, Rohrmeister K, Husslein P. Klinische erfahrungen mit dem oxytocin rezeptor antagonisten atosiban bei drohender frühgeburt [Treatment with the oxytocin receptor antagonist atosiban in patients with risk of preterm delivery]. Geburtsh Frauenheilk 2001; 61: 1–6.
- Ohlsson A. Treatments of preterm premature rupture of the membranes: a meta-analysis. Am J Obstet Gynecol 1989; 160: 890–906.